Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00425594 · ClinicalTrials.gov registry record · Phase 4
A Safety and Efficacy Evaluation of 3 Bowel Preparations in the Pediatric Population
A Phase 4 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT00425594 is a Phase 4 study that has completed, run by Braintree Laboratories. The registered enrollment target is 150 participants.
The verdict
NCT00425594, a Phase 4 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
This randomized, parallel, multi-center, single-blind study is designed to compare the safety and efficacy of 3 bowel preparations in pediatric subjects scheduled to undergo a colonoscopy for a routinely accepted indication.
Interventions
- DRUG HalfLytely and Bisacodyl Tablets - Formulation 1
- DRUG HalfLytely and Bisacodyl Tablets - Formulation 2
- DRUG NuLYTELY
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2007-01 |
| Est. Completion | 2007-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00425594
The ClinicalTrials.gov registry entry for NCT00425594 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which HalfLytely and Bisacodyl Tablets - Formulation 1 is the first listed.
NCT00425594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00425594 about?
NCT00425594 is a clinical study titled "A Safety and Efficacy Evaluation of 3 Bowel Preparations in the Pediatric Population". This randomized, parallel, multi-center, single-blind study is designed to compare the safety and efficacy of 3 bowel preparations in pediatric subjects scheduled to undergo a colonoscopy for a routinely accepted indication.
What is the current status of trial NCT00425594?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2007-01. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00425594?
The interventions under investigation include: HalfLytely and Bisacodyl Tablets - Formulation 1 (DRUG), HalfLytely and Bisacodyl Tablets - Formulation 2 (DRUG), NuLYTELY (DRUG).
Who is sponsoring clinical trial NCT00425594?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.